Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity Fulltext Access 5 Pages 2005
Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: New insights into the biology of TNF-alpha giving new treatment opportunities-the role of bupropion Fulltext Access 5 Pages 2005
Identification of leukemia-associated antigens in chronic myeloid leukemia by proteomic analysis Fulltext Access 5 Pages 2005
Idiopathic hypereosinophilic syndrome: a case evolving in B-lymphoblastic lymphoma Fulltext Access 5 Pages 2005
Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells Fulltext Access 5 Pages 2005
Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemia Fulltext Access 5 Pages 2005
Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection Fulltext Access 5 Pages 2005
Up-regulation of DNA methyltransferases DNMT1, 3A, and 3B in myelodysplastic syndrome Fulltext Access 5 Pages 2005
Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment Fulltext Access 5 Pages 2005
Dimethylsulfoxide induces upregulation of tumor suppressor protein PTEN through nuclear factor-κB activation in HL-60 cells Fulltext Access 5 Pages 2005
Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia Fulltext Access 5 Pages 2005
Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells Fulltext Access 5 Pages 2005
Quiescence of hematopoietic stem cells and maintenance of the stem cell pool is not dependent on TGF-β signaling in vivo Fulltext Access 5 Pages 2005
Influence of telomere length on short-term recovery after allogeneic stem cell transplantation Fulltext Access 5 Pages 2005
Erratum to “Responses of keratinocytes to substrate-bound vitronectin: Growth factor complexes” [Exp. Cell Res. 305 (2004) 221-232] Fulltext Access 5 Pages 2005
Laminin-1 and epidermal growth factor family members co-stimulate fetal pancreas cell proliferation and colony formation Fulltext Access 5 Pages 2005
Compte rendu de la 23e réunion de l'European Society for Therapeutic Radiology and Oncology (ESTRO). Amsterdam, 24-28 octobre 2004 Fulltext Access 5 Pages 2005
Mélanome malin des fosses nasales : considérations cliniques et thérapeutiques à propos de trois cas Fulltext Access 5 Pages 2005
Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter Fulltext Access 5 Pages 2005
Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants Fulltext Access 5 Pages 2005
Insect cell conditioned medium contains an endoglycosidase able to liberate chondroitin sulfate chains from aggrecan Fulltext Access 5 Pages 2005
Detection of autoantibodies to livin and survivin in Sera from lung cancer patients Fulltext Access 5 Pages 2005
Consensus report: Pretreatment minimal staging and treatment of potentially resectable malignant pleural mesothelioma Fulltext Access 5 Pages 2005
Site-related expression of metastasis-associated and signaling molecules in malignant mesothelioma-a new model for the study of tumor biology and disease progression Fulltext Access 5 Pages 2005
Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer Fulltext Access 5 Pages 2005
High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia Fulltext Access 5 Pages 2005
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma Fulltext Access 5 Pages 2005
Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer Fulltext Access 5 Pages 2005
Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen Fulltext Access 5 Pages 2005
Breast cancer risk in a large cohort of female antidepressant medication users Fulltext Access 5 Pages 2005
Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer Fulltext Access 5 Pages 2005
E41. Dilemmas in management: The controversial role of chemotherapy in PS 2 advanced NSCLC Fulltext Access 5 Pages 2005
Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation Fulltext Access 5 Pages 2005
Phase II pilot trial of gemtuzumab ozogamicin (GO) as first line therapy in acute myeloid leukemia patients age 65 or older Fulltext Access 5 Pages 2005
Persistence of various chromosomal aberrations in recipient cells during complete remission after bone marrow transplantation followed by graft rejection Fulltext Access 5 Pages 2005
Assessment and follow-up of the proportion of T315I mutant BCR-ABL transcripts can guide appropriate therapeutic decision making in CML patients Fulltext Access 5 Pages 2005
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute mye Fulltext Access 5 Pages 2005
Rituximab therapy of lymphoma is enhanced by orally administered (1 â 3),(1 â 4)-d-β-glucan Fulltext Access 5 Pages 2005
A morphometric approach for the evaluation of angiogenesis in acute lymphoblastic leukemia of childhood Fulltext Access 5 Pages 2005
Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia Fulltext Access 5 Pages 2005
Coût du contrôle de qualité en radiothérapie : besoins humains et matériels Fulltext Access 5 Pages 2005
RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma Fulltext Access 5 Pages 2005
The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC) Fulltext Access 5 Pages 2005
Assessment of the value of confirming responses in clinical trials in oncology Fulltext Access 5 Pages 2005
No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors Fulltext Access 5 Pages 2005
Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-l-carnitine Fulltext Access 5 Pages 2005
Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort Fulltext Access 5 Pages 2005
Serum carcinoembryonic antigen as a predictive marker for sensitivity to gefitinib in advanced non-small cell lung cancer Fulltext Access 5 Pages 2005
Les traitements par les radiations ionisantes dans les lymphomes. Indications actuelles et futures Fulltext Access 5 Pages 2005
Place de l'association de radiothérapie et d'hormonothérapie dans les cancers de la prostate Fulltext Access 5 Pages 2005
Endometrial cancer: Population attributable risks from reproductive, familial and socioeconomic factors Fulltext Access 5 Pages 2005
Public awareness about risk factors could pose problems for case-control studies: The example of sunbed use and cutaneous melanoma Fulltext Access 5 Pages 2005
An assessment of the efficacy of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations Fulltext Access 5 Pages 2005
Combined Pap and HPV testing in primary screening for cervical abnormalities: Should HPV detection be delayed until age 35? Fulltext Access 5 Pages 2005
Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study Fulltext Access 5 Pages 2005
Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes Fulltext Access 5 Pages 2005
Human glutathion S-transferase A1 polymorphism and susceptibility to urothelial cancer in the Japanese population Fulltext Access 5 Pages 2005
The missense mutations in the candidate prostate cancer gene ELAC2 do not alter enzymatic properties of its product Fulltext Access 5 Pages 2005
Candidates for surgery in the combined modality therapy of stage III non-small cell lung cancer Fulltext Access 5 Pages 2005
Gemcitabine plus docetaxel versus capecitabine plus docetaxel forpatients with anthracycline-pretreated metastatic breast cancer: a review of the results of a European Phase III trial Fulltext Access 5 Pages 2005
Phase I study of concomitant chemoradiation with raltitrexed in locally advanced head and neck cancer Fulltext Access 5 Pages 2005
Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994) Fulltext Access 5 Pages 2005
A survey of breast cancer awareness and knowledge in a Western population: lots of light but little illumination Fulltext Access 5 Pages 2005
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20 Fulltext Access 5 Pages 2005
Increased risk of breast cancer development after diagnosis of salivary gland tumour Fulltext Access 5 Pages 2005